Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 5
|
pp. 7499–7516
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
Back to article
Figure 6
(6 of 6)
−
100%
+
Figure 6.
Survival analysis for BDKRB2 in pan-glioma (
A
,
D
), LGG (
B
,
E
) and GBM (
C
,
F
).
